I have dry eye, what are my treatment options?

dry eye

I think I have dry eye, what are my treatment options? At Price Vision Group, we have a comprehensive list of treatment options for dry eye (ocular surface disorder) depending on the level of severity. The first step is to identify the symptoms of dry eye. What are the symptoms of dry eye? People suffering…

Read More

Price Vision Group Becomes First in Indiana to Treat Degenerative Corneal Disease, Neurotrophic Keratitis, with New FDA-Approved Drug

Price Vision Group

Indianapolis, IN – Dr. Matthew Feng of Price Vision Group will be the first ophthalmologist in Indiana to use the new FDA-approved drug, Oxervate™ (cenegermin). The patient, Tina Hunter, has vision loss due to neurotrophic keratitis (NK). NK is a rare, degenerative corneal disease for which previous treatments include artificial tears or autologous serum tears, which are customLeer Más

Read More

I have been told I am not a candidate for LASIK because my corneas are too thin. Does that mean I am stuck in these glasses and contact lenses?

LASIK,Refractive Surgery,Visian ICL

There are other refractive procedures that can eliminate your need for glasses even if your corneas are too thin for LASIK. During a refractive exam at Price Vision Group, many special tests are performed to ensure you are indeed a good candidate for LASIK, including corneal thickness. The average corneal thickness is between 520 micronsLeer Más

Read More

This Little Hole

Visian ICL

THIS LITTLE HOLE by Dr. Francis Price Why is this little hole such a big deal? The little hole is only 360 microns (.36 mm) in diameter but it makes a world of difference for safety and visual quality.  The little hole is the small central port placed in the middle of an ICL (Implantable Collamer…

Read More

Price Vision Group Participating in Clinical Study of Investigational Growth Factor Treatment for Eye Disorder, Fuchs Endothelial Corneal Dystrophy

Price Vision Group,Research

Indianapolis, IN – March 10, 2021 – Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use an experimental drug treatment in conjunction with a surgical procedure that treats the back surface of the cornea to restore vision in patients with a condition calledLeer Más

Read More

Trefoil Therapeutics Partners With Price Vision Group for Patients with Corneal Endothelial Dystrophies

Cornea Transplantation,Price Vision Group

Trefoil Therapeutics Begins First Clinical Trial at Price Vision Group for Patients with Corneal Endothelial Dystrophies SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics today announced it has initiated the first clinical trial of its engineered Fibroblast Growth Factor-1 TTHX1114 for the treatment of people with corneal endothelial dystrophies (CED), including Fuchs Endothelial Corneal Dystrophy. T

Read More

Our response to COVID-19

Price Vision Group

In the following video, Dr. Price gives an update on Price Vision Group and outlines the steps we’re taking to keep our patients and staff safe while maintaining the care of our patients. Some highlights of the message: Non-emergency surgeries will be postponed Follow-up appointments will be kept if the doctor determines that the patientLeer Más

Read More